Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Avascular necrosis (AVN), also called osteonecrosis, ischemic bone necrosis, or aseptic necrosis, is a condition that occurs due to loss of blood flow to the bone. The condition mostly occurs in the hip however, other common sites include ankle, knee, and shoulder. Individuals between the age of 20 and 50 years are more susceptible to avascular necrosis. Most cases of avascular necrosis occur due to an underlying health problem or injury. Moreover, factors such as increased intake of corticosteroids and alcohol may cause fatty substances to build in the blood vessels and decrease the blood supply to the bones, eventually causing avascular necrosis. Treatment for this condition depends on a number of factors, including age, disease stage, location, and amount of bone damage.
Market Dynamics
Growth of avascular necrosis market is primarily driven by factors such as increasing incidence of avascular necrosis, high demand for non-invasive treatment, and increasing dependence on surgery to cure avascular necrosis. According to Bone Therapeutics report in 2017, around 170,000 patients were suffering from avascular necrosis in the U.S., Europe, and Japan. Moreover, side effects from various medicines taken during cancer, HIV/AIDS, osteoporosis, osteoarthritis, blood disorders, or medical treatment such as chemotherapy, radiation therapy, high-dosage of steroids, and organ transplants can increase chances of developing avascular necrosis. However, delay in diagnosis due to asymptomatic nature of this condition at early stage and high cost of surgical treatments for avascular necrosis are the major factors hampering growth of the avascular necrosis market.
Key features of the study:
This report provides in-depth analysis of the avascular necrosis market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 - 2026, considering 2017, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global avascular necrosis market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Bone Therapeutics, Boehringer Ingelheim GmbH, Bayer AG, Enzo Biochem Inc., Ethicon Inc., Eli Lilly and Company, Grifols SA, Integra LifeSciences Corporation, K-Stemcell Co Ltd., Medtronic Plc, Merck KGaA, Pfizer Inc., Sanofi SA, Stryker Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global avascular necrosis market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for avascular necrosis products, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
Global Avascular Necrosis Market, By Type:
Trauma Related Avascular Necrosis
Non-Trauma Related Avascular Necrosis
Global Avascular Necrosis Market, By Treatment:
Drug Based
Surgery
Core decompression surgery
Osteotomy
Bone graft
Total joint replacement
Global Avascular Necrosis Market, By Region:
North America
By Country:
U.S.
Canada
By Type:
Trauma Related Avascular Necrosis
Non-Trauma Related Avascular Necrosis
By Treatment:
Drug Based
Surgery
Core decompression surgery
Osteotomy
Bone graft
Total joint replacement
Europe
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
By Type:
Trauma Related Avascular Necrosis
Non-Trauma Related Avascular Necrosis
By Treatment:
Drug Based
Surgery
Core decompression surgery
Osteotomy
Bone graft
Total joint replacement
Asia Pacific
By Country:
Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific
By Type:
Trauma Related Avascular Necrosis
Non-Trauma Related Avascular Necrosis
By Treatment:
Drug Based
Surgery
Core decompression surgery
Osteotomy
Bone graft
Total joint replacement
Latin America
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
By Type:
Trauma Related Avascular Necrosis
Non-Trauma Related Avascular Necrosis
By Treatment:
Drug Based
Surgery
Core decompression surgery
Osteotomy
Bone graft
Total joint replacement
Middle East
By Country:
GCC
Israel
Rest of Middle East
By Type:
Trauma Related Avascular Necrosis
Non-Trauma Related Avascular Necrosis
By Treatment:
Drug Based
Surgery
Core decompression surgery
Osteotomy
Bone graft
Total joint replacement
Africa
By Country:
South Africa
Central Africa
North Africa
By Type:
Trauma Related Avascular Necrosis
Non-Trauma Related Avascular Necrosis
By Treatment:
Drug Based
Surgery
Core decompression surgery
Osteotomy
Bone graft
Total joint replacement
Company Profiles
Bone Therapeutics*
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Boehringer Ingelheim GmbH
Bayer AG
Enzo Biochem Inc.
Ethicon Inc.
Eli Lilly and Company
Grifols SA
Integra LifeSciences Corporation
K-Stemcell Co Ltd.
Medtronic Plc
Merck KGaA
Pfizer Inc.
Sanofi SA
Stryker Corporation
Wright Medical Group N.V.
Zimmer Biomet Holdings
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Type
o Market Snippet, By Treatment
o Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Technological Advancements
o Epidemiology Analysis
o PEST Analysis
o Pipeline Analysis
4. Global Avascular Necrosis Market, By Type, 2016 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2016 - 2026
o Segment Trends
o Trauma Related Avascular Necrosis
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Non-Trauma Related Avascular Necrosis
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
5. Global Avascular Necrosis Market, By Treatment, 2016 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2016 - 2026
o Segment Trends
o Drug-Based
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Surgery-Based
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Core decompression surgery
o Osteotomy
o Bone graft
o Total joint replacement
6. Global Avascular Necrosis Market, By Region, 2016 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, By Region, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, By Region, 2016 - 2026
o Regional Trends
o North America
o Market Size and Forecast, By Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o U.S.
o Canada
o Europe
o Market Size and Forecast, By Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
o Market Size and Forecast, By Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o China
o Japan
o India
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
o Market Size and Forecast, By Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
o Market Size and Forecast, By Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o Northern Africa
o Central Africa
o South Africa
o Middle East
o Market Size and Forecast, By Type, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Treatment, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o GCC Countries
o Israel
o Rest of Middle East
7. Competitive Landscape
o Heat Map Analysis
o Company Profiles
o Bone Therapeutics
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Boehringer Ingelheim GmbH
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Bayer AG
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Enzo Biochem Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Ethicon Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Eli Lilly and Company
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Grifols SA
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Integra LifeSciences Corporation
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o K-Stemcell Co Ltd.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Medtronic Plc
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Merck KGaA
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Pfizer Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Sanofi SA
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Stryker Corporation
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Wright Medical Group N.V.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Zimmer Biomet Holdings
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Analyst Views
8. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 17 market data tables and 21 figures on "Avascular Necrosis Market" - Global forecast to 2026".
